Brentnall, Adam R. http://orcid.org/0000-0001-6327-4357
Atakpa, Emma C.
Hill, Harry http://orcid.org/0000-0002-0908-5595
Santeramo, Ruggiero http://orcid.org/0000-0001-7107-235X
Damiani, Celeste http://orcid.org/0000-0002-1990-6684
Cuzick, Jack
Montana, Giovanni http://orcid.org/0000-0003-3942-3900
Duffy, Stephen W.
Funding for this research was provided by:
Breast Cancer Now (2019DecPR1395)
DH | NIHR | Health Services Research Programme (PR-PRU-1217-21601)
Breast Cancer Now (2019DecPR1395)
Cancer Research UK (C49757/A28689)
Cancer Research UK (C49757/A28689)
Cancer Research UK (C49757/A28689)
DH | NIHR | Health Services Research Programme (PR-PRU-1217-21601)
Article History
Received: 14 July 2023
Accepted: 15 November 2023
First Online: 28 November 2023
Competing interests
: A.R.B. and J.C. declare royalties from CRUK for commercial use of the Tyrer-Cuzick (IBIS) breast cancer risk evaluation algorithm. A.R.B. declares consulting fees from Kings College London. A.R.B. serves on the UK National Screening Committee Research and Methodology subgroup, but this had no role in this manuscript. J.C. declares no non-financial competing interests. All other authors declare no financial or non-financial conflicts of interest.